Quick Answer
Aspira Women’s Health Inc. reported Diluted EPS of $0.93 per share (loss) for fiscal year 2024.
Aspira Women’s Health Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.93 | +48.6% |
| 2023 | -$1.81 | +53.0% |
| 2022 | -$3.85 | -1275.0% |
| 2021 | -$0.28 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.13 | +43.5% | -85.7% |
| June 30, 2025 | -$0.07 | +75.0% | +22.2% |
| March 31, 2025 | -$0.09 | +76.9% | +60.9% |
| September 30, 2024 | -$0.23 | +52.1% | +17.9% |
| June 30, 2024 | -$0.28 | +0.0% | +28.2% |
| March 31, 2024 | -$0.39 | +50.6% | +18.7% |
| September 30, 2023 | -$0.48 | +52.0% | -71.4% |
| June 30, 2023 | -$0.28 | +74.5% | +64.6% |
- Aspira Women’s Health Inc. showed an increase of +48.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2024 period, Aspira Women’s Health Inc.’s diluted eps has declined by 232.1% (from $0.28 per share (loss) to $0.93 per share (loss)).
- The most recent figure is from Aspira Women’s Health Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: